The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|November 1, 1998
The American Journal of Managed Care
- November 1998
- Volume 4
- Issue 11
Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer
Advertisement
Articles in this issue
about 28 years ago
The Ethical Dilemma of Population-Based Medical Decision Makingabout 28 years ago
Methods of Evaluation in Outcomes ResearchAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5